Amundi Raises Stock Holdings in Bruker Corporation $BRKR

Key Points

• Amundi increased its stake in Bruker Corporation by 373.3% during the 1st quarter, raising its holdings to 42,503 shares worth approximately $1.77 million.
• Bruker announced a quarterly dividend of $0.05 per share, set to be paid on October 3rd, providing a yield of 0.6%.
• An earnings report revealed that Bruker missed analyst expectations, reporting an EPS of $0.32 and revenues of $797.4 million in the last quarter, with FY 2025 guidance set between $1.950 - $2.050 EPS.

Amundi boosted its holdings in shares of Bruker Corporation (NASDAQ:BRKR - Free Report) by 373.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,503 shares of the medical research company's stock after acquiring an additional 33,522 shares during the quarter. Amundi's holdings in Bruker were worth $1,774,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Teacher Retirement System of Texas grew its holdings in shares of Bruker by 5.1% during the first quarter. Teacher Retirement System of Texas now owns 29,045 shares of the medical research company's stock valued at $1,212,000 after buying an additional 1,422 shares during the last quarter. Fifth Third Bancorp grew its position in Bruker by 54.2% during the first quarter. Fifth Third Bancorp now owns 1,109 shares of the medical research company's stock valued at $46,000 after buying an additional 390 shares during the period. Wealth Enhancement Advisory Services LLC grew its position in Bruker by 81.2% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 29,826 shares of the medical research company's stock valued at $1,245,000 after buying an additional 13,367 shares during the period. OneDigital Investment Advisors LLC boosted its position in Bruker by 38.0% during the first quarter. OneDigital Investment Advisors LLC now owns 5,522 shares of the medical research company's stock worth $230,000 after purchasing an additional 1,520 shares during the period. Finally, UMB Bank n.a. boosted its position in Bruker by 45.8% during the first quarter. UMB Bank n.a. now owns 1,325 shares of the medical research company's stock worth $55,000 after purchasing an additional 416 shares during the period. 79.52% of the stock is owned by institutional investors.

Bruker Stock Performance

Bruker stock traded up $1.16 during midday trading on Monday, hitting $32.07. The stock had a trading volume of 5,977,140 shares, compared to its average volume of 4,224,383. Bruker Corporation has a 52-week low of $28.53 and a 52-week high of $72.94. The company has a market capitalization of $4.87 billion, a PE ratio of 61.67, a P/E/G ratio of 4.29 and a beta of 1.22. The firm's fifty day moving average is $35.84 and its two-hundred day moving average is $38.73. The company has a current ratio of 1.61, a quick ratio of 0.70 and a debt-to-equity ratio of 1.31.

Bruker (NASDAQ:BRKR - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.33 by ($0.01). The business had revenue of $797.40 million during the quarter, compared to analysts' expectations of $811.17 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. Bruker's revenue was down .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.52 earnings per share. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, research analysts forecast that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 3rd. Stockholders of record on Tuesday, September 23rd will be given a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, September 23rd. This represents a $0.20 annualized dividend and a dividend yield of 0.6%. Bruker's payout ratio is currently 38.46%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Stifel Nicolaus set a $40.00 target price on shares of Bruker and gave the company a "hold" rating in a research note on Tuesday, August 5th. Jefferies Financial Group set a $60.00 target price on shares of Bruker and gave the company a "buy" rating in a report on Monday, August 4th. Bank of America dropped their target price on shares of Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Barclays lowered their price target on Bruker from $46.00 to $43.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Finally, Citigroup lowered their price target on Bruker from $40.00 to $38.00 and set a "neutral" rating for the company in a research report on Monday, August 4th. Five analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $51.30.

Insider Buying and Selling

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of the company's stock in a transaction on Friday, September 12th. The stock was sold at an average price of $32.25, for a total value of $114,003.75. Following the transaction, the director owned 18,016 shares of the company's stock, valued at $581,016. This represents a 16.40% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 27.30% of the stock is owned by company insiders.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.